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Palpable mass is a common complaint presented to the breast surgeon. It is very uncommon for patients to report breast mass
associated with palpable masses in other superficial structures. When these masses are related to systemic granulomatous diseases,
the diagnosis and initiation of specific therapy can be challenging. The purpose of this paper is to report a case initially assessed
by the breast surgeon and ultimately diagnosed as granulomatous variant of T-cell lymphoma, and discuss the main systemic
granulomatous diseases associated with palpable masses involving the breast.
1. Introduction
Palpable mass is a common complaint presented to the breast
surgeon [1]. It is very uncommon for patients to report breast
mass associated with palpable masses in other superficial
structures.
Idiopathic granulomatous mastitis is a rare, chronic,
autoimmune, benign breast disease, which may mimic breast
abscess or malignancy. Although not fully understood, this
disease is familiar to the breast surgeon [2]. In contrast,
the breast surgeon may not be accustomed to seeing sys-
temic granulomatous diseases. These systemic conditions
may initially present as a palpable mass in the breast and
other superficial body structures. Causes are varied and
include tuberculosis; other mycobacteria or fungi infections;
vasculitis, for example,Wegener’s granulomatosis andChurg-
Strauss syndrome; chronic berylliosis or another metal expo-
sure disease; foreign body reactions; and lymphoma [3].
These conditions may be misdiagnosed and initiation of
specific therapy can be challenging [4].
The purpose of this paper is to report a case primarily
assessed by the breast surgeon and ultimately diagnosed
as granulomatous variant of T-cell lymphoma and discuss
the main differential diagnoses of systemic granulomatous
diseases associated with palpable masses involving the breast.
2. Case Report
A55-year-oldAfrican Brazilian female consulted a breast sur-
geon at the Breast Division of the Campinas State University
Hospital about painless, palpable, bilateral breast masses, first
noticed 6 months prior to examination. During this period,
she noticed similarmasses in the right submandibular region,
abdominal wall of the left flank, and left popliteal fossa.
Current complaint included mild exertional dyspnea but
there was no fever or weight loss. Past medical history
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2014, Article ID 146956, 9 pages
http://dx.doi.org/10.1155/2014/146956
2 Case Reports in Medicine
(a) (b)
Figure 1: Bilateral mammography: bilateral mediolateral oblique (a) and craniocaudal (b) mammographic views demonstrate scattered
fibroglandular tissue with global asymmetry and focal skin thickening in the left breast which was classified as moderate suspicious BI-RADS
4c. There was also an isodense, round, circumscribed mass, measuring 12 × 8mm in the outer upper quadrant, requiring complementary
ultrasonography (encircled). Nipples are marked.
included diabetes mellitus and hypertension, controlled by
metformin and hydrochlorothiazide, respectively.
On physical examination, the patient was obese (body
mass index: 33.8 Kg/m2) with a blood pressure of 130 ×
90mmHg. Concerning the palpable masses, with the excep-
tion of the left breast mass, which was ill-defined, all other
masses were circumscribed, fibroelastic, and fixed to deep
planes, ranging in size from 2 to 9 cm. There was no skin
or nipple retraction. The mass on the abdominal wall was
accompanied by skin hyperpigmentation. There was no
evidence of regional lymphadenopathy.
Initially, the breast surgeon suspected primary left breast
cancer. The breast mass associated with the other masses
could be either fortuitous or breast cancer metastasis. The
patient was then referred to bilateral diagnostic mammog-
raphy and ultrasonography for evaluation of breast disease.
She was also referred to abdominal, cervical, popliteal, and
abdominal wall ultrasonography for assessment of the other
masses.
Bilateral mediolateral oblique (MLO) and craniocaudal
(CC) mammographic views demonstrated scattered fibrog-
landular tissue with global asymmetry and focal skin thick-
ening in the left breast (arrow), categorized as moderately
suspicious (BI-RADS 4c) (Figures 1(a) and 1(b)). There was
also an isodense, round, circumscribed mass, measuring
12 × 8mm in the outer upper quadrant, which required
supplemental ultrasonography. The palpable masses in the
right breast were quite lower (near the inframammary fold)
and not identified on routine incidences.
Ultrasonography of the upper outer quadrant of the left
breast confirmed a hypoechoic, irregular, indistinct mass
with internal vascularity, measuring 47 × 16mm (Figure 2(a)).
The circumscribed mass previously identified on left mam-
mography was not recognized on ultrasonography and could
be related to an isoechoic mass or intramammary lymph
node. Ultrasonography of the lower outer quadrant of the
right breast, near the inframammary fold, depicted two
irregular, hypoechoic, circumscribed masses parallel to the
skin, measuring 29 × 9 and 17 × 8mm (Figures 2(b) and 2(c)).
Breast ultrasonography was also categorized as moderately
suspicious (BI-RADS 4c).
Cervical, popliteal, and abdominal wall ultrasonography
confirmed hypoechoic, well-defined masses in the right sub-
mandibular gland topography, gastrocnemius muscle thick-
ness, and subcutaneous tissue, respectively. Details of these
findings are shown in Figures 3(a), 3(b), and 3(c).
Abdominal ultrasonography showed a 49× 36mmhypoe-
choic, ill-defined pancreatic mass (Figure 4(a)). Although
the mass affected the pancreatic head, the patient did not
manifest jaundice. This is justified by the absence of bile duct
compression (Figure 4(b)).
The majority of masses perceived simultaneously by the
patient had a similar ultrasonographic appearance, suggest-
ing that most or all lesions could be related to the same
condition. In contrast, involvement of different structures,
for example, glandular parenchyma, subcutaneous tissue, and
muscle fibers, encouraged us to sample each palpable mass to
ensure that all were responsible for a single condition. Thus,
apart from the submandibular mass, which was evaluated
by fine-needle aspiration biopsy (FNAB), the soft tissue
and breast masses were investigated by ultrasound-guided
percutaneous fragment biopsy with a 14-gauge needle (Bard
Biopsy Systems, Tempe, AZ, USA).
Results of FNAB were unsatisfactory per hemorrhagic
material. Routine hematoxylin-eosin stained sections of
the soft tissue and breast masses, including the left sus-
picious breast mass, revealed lymphocytic granulomatous
eosinophil-rich infiltration. The search for fungal and acid-
fast bacilli (AFB) using, respectively, Grocott and Ziehl-
Neelsen staining was negative. At that point, the pathology
report indicated that inflammatory process was the most
likely diagnosis, including sarcoidosis as a possibility, and
the breast surgeon referred the patient to the rheumatology
outpatient clinic.
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Figure 2: Breast ultrasonography: ultrasonography of the left breast confirmed a hypoechoic, irregular, indistinct mass, with internal
vascularity, measuring 47 × 16mm (a). Ultrasonography of the right breast depicted two irregular, hypoechoic, circumscribed, parallel to
the skin masses measuring 29 × 9mm and 17 × 8mm in the lower outer quadrant, near the inframammary fold (b and c).
(a) (b) (c)
Figure 3: Small parts ultrasonography: cervical (a), popliteal (b), and abdominal wall (c) ultrasonography confirmed hypoechoic, well-defined
masses in right submandibular gland topography, gastrocnemius muscle thickness, and the subcutaneous tissue, measuring 54 × 37mm, 98
× 44mm, and 73 × 47mm, respectively.
On physical examination, the rheumatologist obtained
the same findings as those described by the breast surgeon
two weeks previously but identified slight exophthalmos
associated with right eyelid edema.The patient was admitted
to the rheumatology ward for further investigation.
Hematological, clinical chemistry, and radiological inves-
tigations were as follows.
Serum chemistry: glucose, C-reactive protein, liver
enzymes (alanine aminotransferase, aspartate aminotrans-
ferase, and alkaline phosphatase), and kidney function (BUN
and creatinine) revealed no abnormalities.
Peripheral blood counts: 6.5 103/mm3 total white blood
cells (normal range: 4–10); differential white blood cells
revealing eosinophilia with 1.5 103 (23.5%) eosinophils (nor-
mal range: 0–0.45); 5.2 106/mm3 total red blood cells (normal
range: 4.2–5.4); 13.8 g/dL hemoglobin (normal range: 12–16);
220 103/mm3 platelets (normal range: 150–400).
Abdominal CT confirmed an ultrasonographic mass in
the pancreatic head (Figure 4(c)).Therewere no othermasses
or lymph node enlargement.
Chest X-ray revealed ill-defined opacities in both lungs,
especially in the middle and inferior field of the right lung.
There was nomediastinal enlargement, which is a remarkable
sarcoidosis radiographic sign (Figure 5(a)). A chest high-
resolution computed tomography (HRCT) showed multiple
ground-glass opacities in subpleural areas of both lungs,
associated with interlobular septal thickening (Figure 5(b)).
Tuberculin skin test was negative.
Magnetic resonance imaging (MRI) of the brain was
within normal limits, except for enlargement of the lateral
rectus muscle of the right orbit, justifying clinical exophthal-
mos (Figure 6(a)). Head and neckMRI showed an infiltrative
lesion centered in the right masticator space that extended
into the submandibular space involving the submandibular
gland with avid gadolinium enhancement pattern and ill-
defined margins (Figure 6(b)).
Owing to the lack of mediastinal lymph node enlarge-
ment, which is a remarkable sarcoidosis radiographic sign,
bronchoscopy with biopsy was ordered. The exam was con-
sidered normal. Lung biopsy also showed diffuse interstitial
granulomatous chronic inflammation,with a small amount of
eosinophils. The search for fungal and acid-fast bacilli (AFB)
was negative. Microscopy and acid-fast bacilli (AFB) culture
of bronchoalveolar lavage fluid also yielded negative results.
The pneumopathologist indicated that histologic findings
may correspond to Churg-Strauss syndrome.
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Figure 4: Abdominal ultrasonography and tomography: abdominal ultrasonography showed a hypoechoic, ill-defined, pancreatic mass
measuring 49 × 36mm (a). Although the mass affected the pancreatic head, the patient manifested no jaundice. This is justified by the
absence of bile duct compression (b). Coronal abdominal CT imaging revealed a solid ill-defined mass in the pancreatic head (single arrow)
(c) and another similar lesion in the subcutaneous tissue of the left lateral abdominal wall (double arrows) (c).
(a) (b)
Figure 5: Chest X-ray and tomography: chest X-ray revealed ill-defined opacities in both lungs, especially in the middle and inferior field
of the right lung (a). There was no mediastinal enlargement, a remarkable sarcoidosis radiographic sign. Axial high-resolution computer
tomography (HRCT) scan revealedmultiple ground-grass opacities in bilateral subpleural areas, associatedwith interlobular septal thickening
(b).
Incisional biopsy of a larger sample of the abdominal
wall skin mass under local anesthesia was suggested in a
multidisciplinary clinical meeting, since it was an accessible
site. The skin specimen showed a monotonous lymphocytic
infiltration, intermingled by irregular granulomas, and fre-
quent eosinophils, occupying entirely the dermis (Figures
7(a) and 7(b)). Lymphocytes were diffusely positive for T-cell
markers (CD2, CD3, CD5, and CD7) (Figure 7(c)). Search for
fungal and AFB was negative. The histopathologic diagnosis
of granulomatous T-cell non-Hodgkin lymphoma in skin of
the abdomenwas rendered. Patient referral to the hematology
ward was required. Histologic findings in association with
patient’s medical history were considered consistent with
peripheral T-cell extranodal non-Hodgkin lymphoma. The
hematologist sent the patient to PET-CT for lymphoma
staging (Figures 8(a), 8(b), 8(c), 8(d), and 8(e)). There were
hypermetabolic lesions in previously known sites and also in
cervical, axillary, and paravertebral lymph nodes.
Six chemotherapy cycles with CHOEP (Adriamycin/
doxorubicin, cyclophosphamide, vincristine/Oncovin, and
etoposide/Vepesid) were indicated. After 3 chemotherapy
cycles, there was resolution of right exophthalmos and
the mass was no longer clinically palpable. Mammography
confirmed breast lesion resolution (Figures 9(a) and 9(b)).
However, after the 6th chemotherapy cycle, there were still
residual hypermetabolic lesions in the lung and popliteal
fossae identified by PET-CT. The treatment will be now
supplemented with bone marrow transplantation.
3. Discussion
The granulomatous inflammatory reaction is usual in pathol-
ogy, being a manifestation of many infective, toxic, allergic,
autoimmune, and neoplastic diseases [5]. Despite being a
specific inflammatory pattern, it is not a specific histologic
finding of a particular etiology. Pathology findings, even
including immunohistochemical techniques, may not be
useful enough to achieve a definitive diagnosis and state
proper therapy.
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Figure 6:Head andneckmagnetic resonance imaging: axial T2MRI revealed enlargement of the lateral rectusmuscle of right orbit (arrows) (a).
A coronal contrast-enhanced T1 MRI showed an infiltrating lesion centered in the right masticator space extending into the submandibular
space involving the submandibular gland. Note the avid gadolinium enhancement pattern of the lesion and its ill-defined margins (b).
(a) (b) (c)
Figure 7: Pathological diagnosis: routine hematoxylin-eosin stained section of the skin of abdominal wall (a and b) revealed lymphocytic
and granulomatous infiltration, with epithelioid macrophages and sparse eosinophils (original magnification: [100x] and [400x], resp.).
Immunohistochemical study (c) showed positivity for CD3, a T-cell marker (original magnification: [100x]).
In this paperwe discuss themain systemic granulomatous
diseases that may affect the breasts and how they were related
to the reported case.
3.1. Tuberculosis. About one-third of the world’s population
has latent Mycobacterium tuberculosis infection. There has
been a significant rise in the prevalence of nontuberculous
and extrapulmonary mycobacterium infection due to an
aging population, AIDS-related opportunistic infection, and
immigration from tuberculosis-endemic regions [6, 7]. Our
university is located in a country where pulmonary tubercu-
losis is still endemic and tuberculosis infection is a hypothesis
that should always be considered [8, 9].
3.2. Breast Involvement. The breast and other palpable sur-
faces can be primary sites of tuberculosis (TB) infection.
However, Mycobacterium tuberculosis infection represents
only up to 4% of all breast lesions in countries where TB is
endemic [10, 11]. The infection most commonly reaches the
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Figure 8: Positron emission tomography (PET-CT): there were hypermetabolic lesions at previously known locations, such as the right
masticator space (a), right breast (b), left abdominal wall (c), and left popliteal fossa (f), and also locations that were not previously diagnosed
such as left axillary lymph node (d) and the left thigh muscle (e).
(a) (b)
Figure 9: Posttreatment mammography: left breast mediolateral oblique (a) and craniocaudal (b) mammographic views confirmed complete
left breast lesion resolution after the 3rd chemotherapy cycle.
breast through lymphatic spread from the axillary, mediasti-
nal, or cervical nodes or directly from underlying structures
such as the ribs [12, 13].
Due to nonspecific clinical and radiological findings, it
is difficult to make the diagnosis of breast TB [10]. Breast
compromise is usually unilateral, but it may be bilateral [14].
Clinical presentation may include acute abscess, a round,
slowly growing nodular mass, or even a lesion strikingly
similar to breast carcinoma [14]. An associated axillary
lymphadenopathy may be found [12]. Furthermore, breast
TB is paucibacillary. As a result, the tuberculin skin test,
microscopy, culture, and nucleic acid amplification tech-
niques do not have the same diagnostic utility as in pul-
monary tuberculosis [15].
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Therefore, TB infection of the breast and other extrapul-
monary sitesmay bemisdiagnosed as another granulomatous
disease [16]. A granulomatous extrapulmonary condition that
fails to respond to specific therapy should give rise to the
suspicion of culture-negative tuberculosis. In the majority of
cases, the final diagnosis is only possible with a high index of
suspicion [16].
3.3. Sarcoidosis. Sarcoidosis is an enigmatic granulomatous
systemic disease and its etiology has not been clearly eluci-
dated [17]. Sarcoid granulomas can involve any organ, but
more than 90% of patients present with intrathoracic lymph
node enlargement, cutaneous or ocular signs and symptoms,
and pulmonary involvement. Pulmonary compromise is the
predominant clinical feature [18]. Ocular disease occurs in
approximately one-third of sarcoidosis patients. [19]. Occa-
sionally, the clinical presentation of sarcoidosis includes
signs and symptoms involving the head and neck [20]. It is
usually a diagnosis of exclusion that is based on compatible
clinical/radiological findings and supported by histologic
evidence in one or more organs.
Classic chest radiographic imaging, either as an initial
workup of respiratory symptoms or as an incidental finding,
may reveal bilateral hilar lymphadenopathy and/or reticular
parenchymal opacities [19]. High-resolution chest CT may
reveal a variety of additional abnormalities, including nodu-
larity, bronchial wall thickening, and stranding predomi-
nantly in themiddle and apical regions of the lungs [21].These
findingswere not clear on chest imaging of the case described.
A biopsy specimen should be obtained from the com-
promised organ that is most easily accessed [17]. In the case
described, because of the different structures involved, for
example, the glandular parenchyma, subcutaneous tissue,
and muscle, we chose to sample each palpable mass to
ensure that all accounted for a single condition. Sarcoidosis
may mimic or occur concomitantly with malignancy [22].
Furthermore, since sarcoidosis is a diagnosis of exclusion,
the physician should always maintain a healthy degree of
skepticism concerning the diagnosis [3]. On the other hand,
due to lack of specificity of granulomatous diseases and the
continued high prevalence of tuberculosis in our country,
many sarcoidosis patients aremisdiagnosedwith tuberculosis
and treated for the condition [23].
3.4. Breast Involvement. Sarcoidosis of the breast occurs in
less than 1% of sarcoidosis patients [24]. The majority of
cases occur in patients who were previously diagnosed with
sarcoidosis in other anatomic sites. Thus, breast mass as the
primary manifestation of sarcoidosis is extremely rare [25].
There has been no description of uniform clinical findings
[26–28]. However, lesions may be fixed or demonstrate skin
dimpling and peau d’orange appearance resembling carci-
noma [22, 25]. Thus, breast sarcoidosis on mammography
and ultrasonography may also mimic malignancy, including
enlarged axillary lymph nodes [22, 29].
3.5. Churg-Strauss Syndrome. Eosinophilic granulomatosis
with polyangiitis or Churg-Strauss syndrome is a sys-
temic granulomatous small-vessel vasculitis associated with
eosinophilia [30, 31]. Asthma is a well-established and
prominent clinical hallmark [30–32].The precise mechanism
of pathogenesis has only been partly elucidated [31]. The
syndrome commonly manifests with upper airway tract and
lung involvement, peripheral neuropathy, and cardiac and
skin lesions [33]. Cardiac involvement is the major cause of
early death and poor long-term prognosis [34, 35]. Migratory
infiltrates visualized on chest radiography are a key feature
of Churg-Strauss syndrome but only 64% of patients had
abnormal findings on chest X-rays [36].
In the present case, although eosinophilia was in agree-
mentwith the diagnosis of Churg-Strauss, the absence of clin-
ical symptoms such as asthma or neuropathywas inconsistent
with this syndrome.
3.6. Breast Involvement. Although rare, breast vasculitis may
be an isolated finding or amanifestation of systemic vasculitis
[37].The clinical appearance often resembles malignancy but
a dramatic response to steroid therapy can be expected [37,
38].
The early phase of Churg-Strauss syndrome is charac-
terized by extravascular eosinophilic tissue infiltration in
virtually any organ.However, breast involvement is extremely
rare [31, 39]. It has been previously reported that masses and
mastitis are manifestations of breast compromise [38, 40].
3.7. Lymphoma. Lymphoma is a large group of lympho-
cyte cancers. There are two basic categories of lymphomas:
Hodgkin and non-Hodgkin lymphoma. Hodgkin lymphoma
is marked by the presence of the Reed-Sternberg cell. Non-
Hodgkin lymphoma includes a large, diverse group of can-
cers. Prognosis and treatment depend on the lymphoma type
and stage [41]. Immunohistochemical study plays a key role
in the classification and subclassification of lymphomas by
detection of lineage-specific antigens [42].
The occurrence of epithelioid cell granuloma is associated
with many neoplasms, including lymphoma, which may
cause difficulties with interpretation and delay in making the
final diagnosis [43].
3.8. Breast Involvement. Primary breast lymphomas usually
account for <1% of all non-Hodgkin lymphomas and malig-
nant breast neoplasms [44]. The low prevalence may be
related to the very small amount of lymphoid tissue contained
in the breast [45].
Breast lymphoma may occur either as a primary or as
a secondary lesion. For the diagnosis of primary breast
lymphoma, it has been proposed that the breast should be
the first or major site of disease presentation.There should be
no evidence of lymphoma elsewhere, except for the ipsilateral
axillary node [46]. Secondary breast lymphoma, as in the case
described, is more common [47]. On the other hand, it was
found that 94% of breast lymphomas were of B-cell lineage
and only 6% were of T-cell type, as in the case reported [47].
The most common symptom of breast lymphoma is a
painless, palpable mass. Nipple retraction or discharge and
skin changes can also rarely occur [44, 47]. Radiological
findings associated with other breast malignancies, such as
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calcifications, spiculations, or architectural distortions, are
extremely rare [45].
The majority of B-cell breast lymphomas occur as pal-
pable masses, whereas skin changes, edema, and local ten-
derness are more commonly associated with T-cell lym-
phomas [45, 48]. Ipsilateral axillary lymphadenopathy has
been reported in 13% to 50% of cases [49].
The diagnosis and classification of lymphomas may
depend on clinical-pathological correlation. This is of
paramount importance since a breast mass containing lym-
phoma cells does not require excision, in contrast to breast
carcinoma. Therefore, to avoid unnecessary treatment, the
breast surgeon must be aware of breast lymphoma, especially
when atypical clinical and radiological findings are encoun-
tered.
4. Conclusion
The report of palpable masses in both the breast and other
superficial structures may be related to rare systemic gran-
ulomatous diseases. Minimal invasive diagnosis (e.g., core
needle biopsy) is essential to guide the process of differential
diagnosis. However, a multidisciplinary approach including
breast surgeon, rheumatologist, hematologist, infectious dis-
ease specialist, dermatologist, pathologist, and radiologist
may be necessary to achieve a definitive diagnosis and proper
treatment.
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